RET and medullary thyroid gland carcinoma: The remaining 79 tested patients were negative for germline pathogenic variants; however, 2 of these patients had a clinical diagnosis of MEN2A (PHEO and medullary thyroid carcinoma) but no germline RET pathogenic variants were identified.